Security record · archived quarter
NEO
NeoGenomics, Inc. · Healthcare · Medical - Diagnostics & Research
7Tracked holders
—Δ holders
5.49MShares held
$76.11MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 96 | +7 | 89.82M | $1.31B | +13 | −6 |
| Q1 2026 | 92 | +1 | 80.37M | $596.13M | +7 | −6 |
| Q4 2025 | 90 | +1 | 81.69M | $948.79M | +1 | — |
| Q3 2025 | 14 | 0 | 59.68M | $460.71M | — | — |
| Q2 2025 | 11 | 0 | 47.11M | $344.36M | +2 | −2 |
| Q1 2025 | 8 | 0 | 15.46M | $146.75M | +2 | −2 |
| Q4 2024 | 8 | 0 | 10.24M | $168.75M | — | — |
| Q3 2024 | 7 | 0 | 4.10M | $60.43M | +2 | −2 |
| Q2 2024 | 7 | — | 5.49M | $76.11M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 3.02M | — | $41.84M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 3.02M | — | $41.84M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Point72 Asset Management ✦ | 1.03M | — | $14.31M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Norges Bank ✦ (passive) | 606.34K | — | $8.41M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 588.59K | — | $8.16M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 588.59K | — | $8.16M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 166.56K | — | $2.31M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 166.56K | — | $2.31M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Bridgewater Associates ✦ | 62.73K | — | $870,037 | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 15.30K | — | $212,211 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 66.00K shares, $60,522 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Aug 14
SC 13G/A — First Light Asset Management, LLC
Jul 30
SC 13G — FIRST TRUST PORTFOLIOS LP
Jul 30
SC 13G/A — BlackRock, Inc.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API